Our findings suggest that patient-related features, COVID-19 severity, and anti-SARS-CoV-2 vaccination, rather than WM treatment char- acteristics, influence the outcome of WM patients with SARS- CoV-2 infection.
SARS-CoV-2 Infection in Patients with Waldenstrom's Macroglobulinemia: A Multicenter International Cohort Study
Arcaini L.;
2023-01-01
Abstract
Our findings suggest that patient-related features, COVID-19 severity, and anti-SARS-CoV-2 vaccination, rather than WM treatment char- acteristics, influence the outcome of WM patients with SARS- CoV-2 infection.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
